XU Xue-jun, TAO Qing, XU De-qin. Determination of fluoxetine hydrochloride in plasma by HPLC[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(3): 222-225. doi: 10.3969/j.issn.1006-0111.2012.03.019
Citation:
|
XU Xue-jun, TAO Qing, XU De-qin. Determination of fluoxetine hydrochloride in plasma by HPLC[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(3): 222-225. doi: 10.3969/j.issn.1006-0111.2012.03.019
|
Determination of fluoxetine hydrochloride in plasma by HPLC
- 1.
Department of Pharmacy, Anhui General Hospital of the Chinese People's Armed Police Forces, Hefei 230061, China
- 2.
Department of Pharmacy ,The 108th Hospital of PLA, Shanghai 200336,China
- Received Date: 2012-02-10
- Rev Recd Date:
2012-03-27
-
Abstract
Objective To establish and optimize a simple, rapid, reliable, high sensitive and high selective method for the determination of fluoxetine hydrochloride in plasma by high-performance liquid chromatographic (HPLC) so as to monitor the clinical drug use. Methods The plasma samples were deproteined by acetonitrile. Separation was performed on a Hypersil ODS2 column(5 μm, 4.6 mm×200 mm). The mobile phase contained acetonitrile-25 mmol/ L phosphate buffer(pH6.5)(34:66). The flow rate and sample volume injected were 1.2 ml/min and 20 μl, respectively. Detection wavelength was 227 nm. Results The calibration curve of fluoxetine hydrochloride in plasma was linear in the concentration range of 0.5~50 ng/ml and coefficient was 0.996 9. The intra-assay precision did not exceed 8.06% and inter-assay precision did not exceed 10.46% for low, medium and high quality samples, respectively. The average recovery of the described method was 91.7%,97.06% and 100.75%, respectively. Conclusion In comparison with previous work, the improved chromatographic method was more economical, less polluted and better protected column, besides simple preparation of plasma samples, high reproducibility, and high selectivity.
-
References
[1]
|
Cheer SM, Goa KL. Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness[J]. Drugs, 2001, 61(1)∶81. |
[2]
|
汪春运,臧家平. 氟西汀的临床应用[J]. 医药导报,2005,24(10):897. |
[3]
|
刘伟忠,陈清霞,黄伟侨,等. 高效液相色谱法同时测定人血浆中氯氮平与氟西汀的浓度[J]. 广东药学院学报,2011,27(3):243. |
[4]
|
李迎春,姚国灿,郭兴杰,等. 高效液相色谱法测定大鼠脑微渗析液中氟西汀的浓度[J]. 中国药房,2006,17(5):341. |
[5]
|
何 娟,周志凌,李焕德. HPLC-MS同时测定4种新型抗抑郁药物的血药浓度[J]. 药物分析杂志,2005,25(12):1428. |
[6]
|
贾晶莹, 张梦琪, 桂雨舟, 等. 液相色谱-串联质谱法同时测定7种抗抑郁类和5种抗精神病类药物的血药浓度[J]. 中国药物应用与监测,2010,7(5):272. |
[7]
|
Franceschi L, Faggiani A, Furlanut M. A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies[J]. J Pharm Biomed Anal. 2009, 49(2):554. |
[8]
|
肖 红, 周 群, 张石宁, 等. HPLC测定人血清中氟西汀的浓度[J]. 江苏药学与临床研究, 2000,8(4):36 . |
[9]
|
李 玲,袁 波,朱荣申, 等. 高效液相色谱法检测抑郁症患者血清中氟西汀的浓度[J]. 中国药学杂志, 2002, 37(l1):855. |
[10]
|
邵庆翔,李 川,张美云,等. 盐酸氟西汀分散片和胶囊的生物等效性研究[J]. 中国新药杂志,2003,12(4):277. |
-
-
Proportional views
-